Guidance

National protocol for Comirnaty® Original/Omicron BA.1 (15/15 micrograms)/dose COVID-19 mRNA vaccine

Protocol for the administration of Comirnaty® Original/Omicron BA.1 (15/15 micrograms)/dose COVID-19 mRNA vaccine to individuals in accordance with the national COVID-19 vaccination programme.

From:
UK Health Security Agency
Published
21 September 2022
Last updated
22 September 2022 — See all updates

This publication was withdrawn on

This protocol has been superseded by the COVID-19 adult and children 5 to 17 years national protocols.

Applies to England

Documents

[Withdrawn] National protocol for Comirnaty® Original/Omicron BA.1 (15/15 micrograms)/dose COVID-19 mRNA vaccine

Ref: UKHSA gateway number GOV-13249

MS Word Document, 214 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This protocol is for the administration of Comirnaty® Original/Omicron BA.1 (15/15 micrograms)/dose COVID-19 mRNA vaccine by appropriately trained persons.

National protocol for Comirnaty® Original/Omicron BA.1 (15/15 micrograms)/dose COVID-19 mRNA vaccine version 2.00 is valid from 14 September 2022 to 15 September 2023.

Published 21 September 2022
Last updated 22 September 2022 + show all updates

  1. Added version 2.00 – details of changes on page 3.

  2. First published.

Related content